Screener
Immunome IMNM Business Segments — Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Immunome’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other direct research and development | 9,971 | 4,673 |
| Indirect research and development(2) | 16,314 | 10,337 |
| General and administrative(3) | 8,649 | 7,376 |
| Other segment expenses(4) | 8,556 | 6,314 |
| Total operating expenses | 59,331 | 47,562 |
| Loss from operations | (59,331) | (44,636) |
| Interest income | 5,492 | 2,996 |
| Net loss | $(53,839) | $(41,640) |
Item 1. Financial Statements.
FAQ
- What is Immunome's business segments — operating income?
- Immunome (IMNM) reported business segments — operating income of -$59.33M in Q1 2026.
- How has Immunome's business segments — operating income changed year-over-year?
- Immunome's business segments — operating income decreased by 32.9% year-over-year, from -$44.64M to -$59.33M.
- What is the long-term trend for Immunome's business segments — operating income?
- Over 2 years (2023 to 2025), Immunome's business segments — operating income has grown at a 43.0% compound annual growth rate (CAGR), from -$109.53M to -$224.11M.
- What does business segments — operating income mean?
- Calculated as the segment's revenue minus its total operating expenses, representing the profitability of the core business activities before interest and taxes. For early-stage companies, this is typically a loss, reflecting the investment phase of the business. It serves as the primary gauge for the segment's operational viability and path toward self-sustainability.
Ask your AI about Immunome's business segments — operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude